Aller au contenu principal
Retour à l'annuaire
RhumatologueMédecins généralistes et spécialistes👤 Libéral intégral

M. Docteur MAXIME SONDAG

📍 Mulhouse (68)Libéral💶 Secteur 2RPPS 10100955359
📊 Reconnaissance scientifique : 10/100📝 45 articles publiés📚 HAL (6)

Diplômes

🎓 DES & spécialité ordinale

  • DES Rhumatologie
  • Rhumatologie (SM)

🎓 Diplômes

  • DE Docteur en médecine

Source : Annuaire Santé ANS (FHIR Practitioner.qualification) · Mises à jour quotidiennes.

Activité de recherche & publications

Source : bases de données publiques (OpenAlex, PubMed).

h-index

10

h articles cités ≥ h fois chacun. Un h de 10 = 10 publications avec 10+ citations.

Citations

279

Publications

45

i10-index

10

Thématiques principales

  • Spondyloarthritis Studies and Treatments ×14
  • Rheumatoid Arthritis Research and Therapies ×6
  • Vasculitis and related conditions ×6
  • Bone and Joint Diseases ×6
  • Otitis Media and Relapsing Polychondritis ×6

Affiliations FR : Centre Hospitalier Universitaire de Besançon

Voir sur OpenAlex ↗🆔 ORCID 0000-0002-1901-7959

Source : OpenAlex (CC0, OurResearch). Indicateurs académiques agrégés sur 250 M+ d'œuvres.

Bibliographie

Source : HAL — archive ouverte CCSD/CNRS (couvre articles, chapitres EMC, communications congrès, thèses).

Localisation des cabinets

Adresses géocodées via la Base Adresse Nationale (api-adresse.data.gouv.fr). Précision indicative.

Lieux de consultation

Tarifs & secteur de conventionnement

🟡 Secteur 2 — Honoraires libresSource CNAM (Annuaire santé Ameli)
✓ OPTAM💳 Carte VitaleLibéral intégral
📊 Comprendre le remboursement

Prendre rendez-vous & contact

🗓 Trouver sur Doctolib📇 Ajouter à mes contacts

Lien Doctolib = recherche Google site:doctolib.fr (le 1er résultat est presque toujours le profil correct s'il existe).

Top publications · les plus citées

  • 1
    Utility of 18F-fluoro-dexoxyglucose positron emission tomography for the diagnosis of polymyalgia rheumatica: a controlled study

    Rheumatology (Oxford, England) · 2016

    📚 70 citations🎯 RCR 3.85Top 11% NIH🩺 Clinique
  • 2
    Arthritis occurrence or reactivation under Vedolizumab treatment for inflammatory bowel disease. A four cases report

    Joint bone spine · 2018

    📚 22 citations🎯 RCR 1.02
  • 3
    Standardized Follow-up of Patients with Symptomatic Knee Osteoarthritis Treated with a Single Intra-articular Injection of a Combination of Cross-Linked Hyaluronic Acid and Mannitol

    Clinical medicine insights. Arthritis and musculoskeletal disorders · 2016

    📚 16 citations🔓 Open Access📄 PDF gratuit ↗
    Lire l'abstract Crossref ↓

    Objectives The objective of this study is to obtain pilot data from daily practice conditions of a viscosupplement made of a cross-linked high-molecular-weight hyaluronic acid (HA) combined with mannitol in patients with knee osteoarthritis (KOA). Methods The data of 40 consecutive patients, 29 women and 11 men, who were prospectively followed up for 6 months, using a standardized procedure, were retrospectively analyzed. All patients have received a single intra-articular injection of H Anox-M-XL (4.4 mL), viscosupplement made of a cross-linked HA (16 mg/mL) + mannitol (35 mg/mL), in the target knee. The primary outcome was safety. The secondary end points included 3- and 6-month change in the WOMAC pain (0–50) and WOMAC total (0–240) and patient's global assessment (PGA). Patient's self-assessment of treatment efficacy (0–3) and analgesic consumption were obtained at months 3 and 6. An intent-to-treat analysis was performed. Results Mean (SD) age was 60.7 (13.9) years, and mean BMI was 28.6 (5.0). Kellgren–Lawrence radiological grade was I/II and III/IV in 13 and 27 of the subjects, respectively. The average WOMAC pain and WOMAC total scores at baseline were 21.5 (9.8) and 89.9 (42.8), respectively. Thirty-nine patients completed the follow-up. HAnox-M-XL was well tolerated; two patients experienced knee pain after injection, which resolved within three days. No treatment-related severe adverse event was reported. Mean (SD) variations in WOMAC pain and WOMAC total scores were –8.2 (8.9) and –38.4 (35.6), respectively, at month 6 ( P = 0.001). PGA decreased from 5.5 (2.0) to 3.0 (2.2) ( P = 0.006). Efficacy was rated as good or very good in 76.9% of the cases. Most of the regular analgesics users decreased their consumption. Conclusion Treatment with one injection of 4.4 mL HAnox-M-XL is effective to alleviate KOA symptoms over six months, without safety concern. Controlled trials are needed to confirm these pilot data.

Publications scientifiques (19) — classées par pathologie

Source PubMed · Recherche par auteur (homonymes possibles, vérifier l'affiliation).

Transversal12

▼

Anti-TNF3

▼

Corticothérapie1

▼

Goutte1

▼

Ostéoporose1

▼

Revue générale1

▼

Partager cette fiche

in LinkedIn🟢 WhatsApp✉ Email

Données ANS publiques (Licence Ouverte 2.0) · Enrichissements MonRhumato 100 % opt-in · Toute personne référencée peut demander la suppression ou la rectification.